...
机译:
School of Biomedical EngineeringResearch and Engineering Center of Biomedical MaterialsAnhui Medical UniversityHefei 230032, P. R. China;
Department of OphthalmologyThe Second Affiliated Hospital of Anhui Medical UniversityHefei 230601, P. R. China,Department of Clinical MedicineThe Second School of Clinical MedicineAnhui Medical UniversityHefei 230032, P. R. China,Department of LaboratoryFengtai County First People’s HospitalHuainan 232101, P. R. China;
Department of Clinical MedicineThe Second School of Clinical MedicineAnhui Medical UniversityHefei 230032, P. R. ChinaDepartment of Clinical MedicineThe Second School of Clinical MedicineAnhui Medical UniversityHefei 230032, P. R. China,School of Biomedical EngineeringResearch and Engineering Center of Biomedical MaterialsAnhui Medical UniversityHefei 230032, P. R. ChinaDepartment of LaboratoryFengtai County First People’s HospitalHuainan 232101, P. R. ChinaDepartment of OphthalmologyThe Second Affiliated Hospital of Anhui Medical UniversityHefei 230601, P. R. China;
anti-angiogenesis; antioxidants; diabetic retinopathy treatment; Fe-Quer nanozymes; mimetic enzyme activities;
机译:Progression of diabetic retinopathy following cataract surgery: can it be prevented?
机译:Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy
机译:Treatment Activity of a New Pr(III) Coordination Polymer on Diabetic Retinopathy by Regulating miR-107/HMGB1 in Retinal Vascular Cells